Real-world evidence of precision medicine for biliary tract cancer

被引:0
|
作者
Hayashi, Hideyuki [1 ]
Tanishima, Shigeki [2 ]
Fujikura, Tomoka [1 ]
Nakamura, Kohei [1 ]
Ishikawa, Marin [1 ]
Kato, Yasutaka [1 ]
Kawano, Ryutaro [1 ]
Hirata, Kenro [3 ]
Hamamoto, Yasuo [3 ]
Nishihara, Hiroshi [1 ]
机构
[1] Keio Univ, Genom Unit, Keio Canc Ctr, Sch Med, Keio, Japan
[2] Mitsubishi Elect Software Co Ltd, Dept Biomed Informat Dev, Tokyo, Japan
[3] Keio Univ, Keio Canc Ctr, Sch Med, Keio, Japan
关键词
D O I
10.1016/j.annonc.2023.09.238
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MO34-1
引用
收藏
页码:S1417 / S1417
页数:1
相关论文
共 50 条
  • [21] Applied precision cancer medicine in advanced biliary tract cancer
    Taghizadeh, H.
    Muellauer, L.
    Kieler, M.
    Prager, G.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Real-world treatment outcomes of metastatic biliary tract cancer in Japan: Tokushukai REAl-world Data project; TREAD 04
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Taguri, Masataka
    Fujimura, Yoshiaki
    Hayashi, Maki
    Sawamukai, Keiji
    Shinozaki, Nobuaki
    Minami, Hironobu
    ANNALS OF ONCOLOGY, 2023, 34 : S1462 - S1462
  • [23] Real-world surgical treatment of thoracic cancer in the era of precision medicine Editorial
    Wei, Guobang
    Chen, Yongbing
    FRONTIERS IN SURGERY, 2022, 9
  • [24] Durvalumab (DUR) effectiveness in advanced biliary tract cancer (aBTC) patients based on real-world data evidence.
    Rodriguez-Pascual, Jesus
    Hernandez, Gema
    Ugidos, Lisardo
    Parralejo, Alejandro
    Rodriguez-Castano, Juan Diego
    Serrano, Juan Jose
    Ayuso, Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 598 - 598
  • [25] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Precision medicine in the real-world: The impact of the genetic testing evolution in metastatic colorectal cancer
    Casebeer, Adrianne Waldman
    Long, Charron
    Antol, Dana Drzayich
    Racsa, Patrick
    Rogstad, Teresa
    Stemple, Charles
    Loy, Bryan A.
    De Souza, Jonas A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Real-world treatment outcomes of metastatic biliary tract cancer patients in Japan: the Tokushukai REAl-world data project 04 (TREAD 04)
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Taguri, Masataka
    Okuda, Tadahisa
    Fujimura, Yoshiaki
    Hayashi, Maki
    Tanaka, Satomi
    Sawamukai, Keiji
    Minami, Hironobu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 70 - 80
  • [28] Analysis of real-world implementation of systemic treatment in biliary tract cancer - a single center analysis
    Zhang, D.
    Dorman, K.
    Haas, M.
    Westphalen, C. B.
    Jens, W.
    Mayerle, J.
    Heinemann, V.
    Boeck, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 129 - 130
  • [29] Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data
    Reimann, Patrick
    Mavroeidi, Ilektra-Antonia
    Burghofer, Jonathan
    Taghizadeh, Hossein
    Webersinke, Gerald
    Kasper, Stefan
    Schreil, Georg
    Morariu, Darius
    Reichinger, Andreas
    Baba, Hideo Andreas
    Kirchweger, Patrick
    Schuler, Martin
    Djanani, Angela
    Prager, Gerald W.
    Rumpold, Holger
    Benda, Magdalena
    Schneider, Eva-Maria
    Mink, Sylvia
    Winder, Thomas
    Doleschal, Bernhard
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [30] A global comparative study on real-world clinical and genomic differences in advanced biliary tract cancer
    Abidoye, Oluseyi
    Hoyek, Celine
    Zheng-Lin, Binbin
    Kosiorek, Heidi E.
    Eslinger, Cody
    Sonbol, Mohamad Bassam
    Wu, Christina
    Tran, Nguyen H.
    Babiker, Hani M.
    Yoshino, Takayuki
    Ikeda, Masafumi
    Morizane, Chigusa
    Bando, Hideaki
    Nakamura, Yoshiaki
    Fujisawa, Takao
    Shibuki, Taro
    Ahn, Daniel H.
    Roberts, Lewis R.
    Borad, Mitesh J.
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 628 - 628